Latest & greatest articles for mammography

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on mammography or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on mammography and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for mammography

121. Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study. Full Text available with Trip Pro

Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study. To evaluate the effect on breast cancer mortality during the first 10 years of the mammography service screening programme that was introduced in Copenhagen in 1991.Cohort study.The mammography service screening programme in Copenhagen, Denmark.All women ever invited to mammography screening in the first 10 years of the programme. Historical, national, and historical national control groups were

2005 BMJ

122. Digital mammography: a screening modality for breast cancer

Digital mammography: a screening modality for breast cancer National Horizon Scanning Unit Horizon scanning prioritising summary Volume 11, Number 5: Digital Mammography: A screening modality for breast cancer. December 2005 © Commonwealth of Australia 2005 [add ISSN] [add Publications Approval Number] This work is copyright. You may download, display, print and reproduce this material in unaltered form only (retaining this notice) for your personal, non-commercial use or use within your (...) Horizon Scanning Unit, Adelaide Health Technology Assessment, Department of Public Health, Mail Drop 511, University of Adelaide, South Australia, 5005.PRIORITISING SUMMARY REGISTER ID: 000179 NAME OF TECHNOLOGY: DIGITAL MAMMOGRAPHY PURPOSE AND TARGET GROUP: SCREENING MODALITY FOR BREAST CANCER STAGE OF DEVELOPMENT (IN AUSTRALIA): Yet to emerge Established Experimental Established but changed indication or modification of technique Investigational Should be taken out of use ? Nearly established

2005 Australia and New Zealand Horizon Scanning Network

123. Screening mammography: a reassessment

Screening mammography: a reassessment Screening mammography: a reassessment Screening mammography: a reassessment Deck W, Kakuma R Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Deck W, Kakuma R. Screening mammography: a reassessment. Montreal: Agence d'evaluation des technologies et des modes d'intervention en sante (AETMIS). AETMIS 05 (...) -03 RE. 2005 Authors' objectives This update of two reports by the Conseil d'Evaluation des technologies de la sante (CETS) published in 1990 and 1993 addresses three questions: (1) What is the strength of the scientific evidence on which screening mammography programs are based? (2) What evidence is there in support of screening for women aged 40 to 49 years? (3) What are the implications of research studies for maximizing the effectiveness of modern programs such as the Programme quebecois de

2005 Health Technology Assessment (HTA) Database.

124. Impact of computer-aided detection prompts on the sensitivity and specificity of screening mammography

Impact of computer-aided detection prompts on the sensitivity and specificity of screening mammography Impact of computer-aided detection prompts on the sensitivity and specificity of screening mammography Impact of computer-aided detection prompts on the sensitivity and specificity of screening mammography Taylor P, Champness J, Given-Wilson R, Johnston K, Potts H Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation (...) of the quality of this assessment has been made for the HTA database. Citation Taylor P, Champness J, Given-Wilson R, Johnston K, Potts H. Impact of computer-aided detection prompts on the sensitivity and specificity of screening mammography. Health Technology Assessment 2005; 9(6): 1-72 Authors' objectives The objective of this study was to determine the value of computer-aided detection (CAD) for breast cancer screening. The impact of the R2 ImageChecker (R) on the sensitivity and specificity

2005 Health Technology Assessment (HTA) Database.

125. A systematic review of mammography educational interventions for low-income women

A systematic review of mammography educational interventions for low-income women A systematic review of mammography educational interventions for low-income women A systematic review of mammography educational interventions for low-income women Bailey T M, Delva J, Gretebeck K, Siefert K, Ismail A CRD summary The review concluded that peer-led interventions providing logistical assistance, based on multi-component strategies, are most effective in increasing uptake of mammography screening (...) in low-income women. This conclusion is limited by the presentation of the available evidence, and also needs to be supported by studies that compare peer-led with non peer-led interventions. Authors' objectives To determine the effectiveness of community-based educational interventions in increasing mammography screening in low-income women. Searching MEDLINE, the Cochrane CENTRAL Register, the Cochrane Database of Systematic Reviews and ISI Web of Science were searched for English language

2005 DARE.

126. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). (Abstract)

Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Women genetically predisposed to breast cancer often develop the disease at a young age when dense breast tissue reduces the sensitivity of X-ray mammography. Our aim was, therefore, to compare contrast enhanced magnetic resonance imaging (CE MRI) with mammography for screening.We did a prospective multicentre cohort study in 649 (...) women aged 35-49 years with a strong family history of breast cancer or a high probability of a BRCA1, BRCA2, or TP53 mutation. We recruited participants from 22 centres in the UK, and offered the women annual screening with CE MRI and mammography for 2-7 years.We diagnosed 35 cancers in the 649 women screened with both mammography and CE MRI (1881 screens): 19 by CE MRI only, six by mammography only, and eight by both, with two interval cases. Sensitivity was significantly higher for CE MRI (77

2005 Lancet

127. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. Full Text available with Trip Pro

Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. Current recommendations for women who have a BRCA1 or BRCA2 mutation are to undergo breast surveillance from age 25 years onward with mammography annually and clinical breast examination (CBE) every 6 months; however, many tumors are detected at a relatively advanced stage. Magnetic resonance imaging (MRI) and ultrasound may improve the ability to detect (...) breast cancer at an early stage.To compare the sensitivity and specificity of 4 methods of breast cancer surveillance (mammography, ultrasound, MRI, and CBE) in women with hereditary susceptibility to breast cancer due to a BRCA1 or BRCA2 mutation.A surveillance study of 236 Canadian women aged 25 to 65 years with BRCA1 or BRCA2 mutations who underwent 1 to 3 annual screening examinations, consisting of MRI, mammography, and ultrasound at a single tertiary care teaching hospital between November 3

2004 JAMA

128. Risk for distant recurrence of breast cancer detected by mammography screening or other methods. Full Text available with Trip Pro

Risk for distant recurrence of breast cancer detected by mammography screening or other methods. Selection of systemic adjuvant therapies for women diagnosed as having breast cancer is based on risk estimations for cancer recurrence. In such estimations, tumors detected by mammography screening are considered to be associated with a similar risk of recurrence as tumors of similar size found by other methods.To compare the risk of recurrence and survival among women with cancerous tumors (...) detected by mammography screening compared with other methods (outside of screening).Retrospective study comparing clinical, histopathological, and biological features of cancerous tumors detected by mammography screening compared with tumors detected outside of screening. Women diagnosed as having breast cancer in 1991 or 1992 were identified from the Finnish Cancer Registry (n = 2842). The median follow-up time was 9.5 years. Cancer biological variables were analyzed from tumor tissue microarrays

2004 JAMA

129. Influence of personal characteristics of individual women on sensitivity and specificity of mammography in the Million Women Study: cohort study. Full Text available with Trip Pro

Influence of personal characteristics of individual women on sensitivity and specificity of mammography in the Million Women Study: cohort study. To examine how lifestyle, hormonal, and other factors influence the sensitivity and specificity of mammography.Women recruited into the Million Women Study completed a questionnaire about various personal factors before routine mammographic screening. A sample of 122,355 women aged 50-64 years were followed for outcome of screening and incident breast

2004 BMJ

130. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. Full Text available with Trip Pro

Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. The value of regular surveillance for breast cancer in women with a genetic or familial predisposition to breast cancer is currently unproven. We compared the efficacy of magnetic resonance imaging (MRI) with that of mammography for screening in this group of high-risk women.Women who had a cumulative lifetime risk of breast cancer of 15 percent or more were screened every six months (...) with a clinical breast examination and once a year by mammography and MRI, with independent readings. The characteristics of the cancers that were detected were compared with the characteristics of those in two different age-matched control groups.We screened 1909 eligible women, including 358 carriers of germ-line mutations. Within a median follow-up period of 2.9 years, 51 tumors (44 invasive cancers, 6 ductal carcinomas in situ, and 1 lymphoma) and 1 lobular carcinoma in situ were detected. The sensitivity

2004 NEJM

131. Relationship between health status and use of screening mammography and Papanicolaou smears among women older than 70 years of age. (Abstract)

Relationship between health status and use of screening mammography and Papanicolaou smears among women older than 70 years of age. Older women whose life expectancy is less than 5 years are unlikely to benefit from screening mammography or Papanicolaou (Pap) smears. Since life expectancy is better predicted by health status than by age alone, guidelines recommend considering an older woman's general health when making screening decisions.To determine whether screening mammography and Pap (...) mammography within the previous 2 years and a screening Pap smear within 3 years.Seventy-eight percent of women reported recent screening mammography, and 77% reported a recent Pap smear. Screening rates decreased with advancing age. However, within each age group, the percentage of women reporting screening did not significantly decrease with worsening health status (P > 0.1 for all comparisons). More than half of women 80 years of age or older in the worst health quartile reported recent screening

2004 Annals of Internal Medicine

132. Effect of breast augmentation on the accuracy of mammography and cancer characteristics. Full Text available with Trip Pro

Effect of breast augmentation on the accuracy of mammography and cancer characteristics. Breast augmentation is not associated with an increased risk of breast cancer; however, implants may interfere with the detection of breast cancer thereby delaying cancer diagnosis in women with augmentation.To determine whether mammography accuracy and tumor characteristics are different for women with and without augmentation.A prospective cohort of 137 women with augmentation and 685 women without (...) augmentation diagnosed with breast cancer between January 1, 1995, and October 15, 2002, matched (1:5) by age, race/ethnicity, previous mammography screening, and mammography registry, and 10 533 women with augmentation and 974 915 women without augmentation and without breast cancer among 7 mammography registries in Denver, Colo; Lebanon, NH; Albuquerque, NM; Chapel Hill, NC; San Francisco, Calif; Seattle, Wash; and Burlington, Vt.Comparison between women with and without augmentation of mammography

2004 JAMA

133. Computer aided detection systems in mammography

Computer aided detection systems in mammography Computer aided detection systems in mammography: a breast cancer detection tool for women attending screening and/or diagnostic mammography services. Computer aided detection systems in mammography: a breast cancer detection tool for women attending screening and/or diagnostic mammography services. Bywood P, Newton S, Merlin T, Braunack-Mayer A, Hiller J E Record Status This is a bibliographic record of a published health technology assessment (...) from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Bywood P, Newton S, Merlin T, Braunack-Mayer A, Hiller J E. Computer aided detection systems in mammography: a breast cancer detection tool for women attending screening and/or diagnostic mammography services. 2004 Authors' objectives

This Horizon Scanning Report is intended for the use of health planners and policy makers. It provides an assessment of the current state

2004 Health Technology Assessment (HTA) Database.

134. A cost-effectiveness comparison of three tailored interventions to increase mammography screening

A cost-effectiveness comparison of three tailored interventions to increase mammography screening Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2004 NHS Economic Evaluation Database.

135. Cost-effectiveness of a tailored intervention to increase screening in HMO women overdue for Pap test and mammography services

Cost-effectiveness of a tailored intervention to increase screening in HMO women overdue for Pap test and mammography services Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2004 NHS Economic Evaluation Database.

136. Comparison of screening mammography in the United States and the United kingdom. Full Text available with Trip Pro

Comparison of screening mammography in the United States and the United kingdom. Screening mammography differs between the United States and the United Kingdom; a direct comparison may suggest methods to improve the practice.To compare screening mammography performance between the United States and the United Kingdom among similar-aged women.Women aged 50 years or older were identified who underwent 5.5 million mammograms from January 1, 1996, to December 31, 1999, within 3 large-scale (...) mammography registries or screening programs: the Breast Cancer Surveillance Consortium (BCSC, n = 978 591) and National Breast and Cervical Cancer Early Detection Program (NBCCEDP, n = 613 388) in the United States; and the National Health Service Breast Screening Program (NHSBSP, n = 3.94 million) in the United Kingdom. A total of 27 612 women were diagnosed with breast cancer (invasive or ductal carcinoma in situ) within 12 months of screening among the 3 groups.Recall rates (recommendation for further

2003 JAMA

137. Evaluation of abnormal mammography results and palpable breast abnormalities. (Abstract)

Evaluation of abnormal mammography results and palpable breast abnormalities. Because approximately 1 in 10 women with a breast lump or abnormal mammography result will have breast cancer, a series of decisions must be taken by a primary care practitioner to exclude or establish a diagnosis of breast cancer among these women.To determine the most accurate and least invasive means to evaluate an abnormal mammography result and a palpable breast abnormality.MEDLINE search (January 1966 to March (...) 2003) for articles and reviews describing the accuracy of clinical examination, biopsy procedures, and radiographic examination for patients with abnormal mammography results or palpable breast abnormalities.The authors reviewed abstracts and selected articles that provided relevant primary data. Studies were included if 1) mammography, fine-needle aspiration biopsy, or core-needle biopsy was performed before a definitive diagnosis was obtained; 2) the study sample included 100 or more women; and 3

2003 Annals of Internal Medicine

138. Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. (Abstract)

Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. The long term effect of mammographic service screening is not well established. We aimed to assess the long-term effect of mammographic screening on death from breast cancer, taking into account potential biases from self-selection, changes in breast cancer incidence, and classification of cause of death.We compared deaths from breast cancer diagnosed in the 20 (...) ) but not in unscreened women (p=0.2). In both 40-69-year and 40-49-year age-groups, reductions in deaths from all cancers and from all-causes in women with breast cancer were consistent with these results.Taking account of potential biases, changes in clinical practice and changes in the incidence of breast cancer, mammography screening is contributing to substantial reductions in breast cancer mortality in these two Swedish counties.

2003 Lancet

139. Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. (Abstract)

Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. The relationships among breast density, age, and use of hormone replacement therapy (HRT) in breast cancer detection have not been fully evaluated.To determine how breast density, age, and use of HRT individually and in combination affect the accuracy of screening mammography.Prospective cohort study.7 population-based mammography registries in North Carolina (...) are important predictors of the accuracy of screening mammography. Although HRT use is not an independent predictor of accuracy, it probably affects accuracy by increasing breast density.

2003 Annals of Internal Medicine

140. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. Full Text available with Trip Pro

Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. The Women's Health Initiative trial of combined estrogen plus progestin was stopped early when overall health risks, including invasive breast cancer, exceeded benefits. Outstanding issues not previously addressed include characteristics of breast cancers observed among women using hormones and whether diagnosis may be influenced by hormone (...) effects on mammography.To determine the relationship among estrogen plus progestin use, breast cancer characteristics, and mammography recommendations.Following a comprehensive breast cancer risk assessment, 16 608 postmenopausal women aged 50 to 79 years with an intact uterus were randomly assigned to receive combined conjugated equine estrogens (0.625 mg/d) plus medroxyprogesterone acetate (2.5 mg/d) or placebo from 1993 to 1998 at 40 clinical centers. Screening mammography and clinical breast

2003 JAMA Controlled trial quality: predicted high